In this article the results of molecular marker p53 examinations were
presented in relation to the following established breast cancer progn
ostic factors: age, histologic type, histologic grade, lymph node invo
lvement, tumor size as well as estrogen a progesterone receptor status
. Twenty one percent of these primary breast cancer specimens exhibite
d the overexpression of p53 protein. Significant associations were fou
nd between p53 overexpression and younger age, high histologic grade a
nd low content of estrogen and progesterone receptors. Identification
of p53-positive breast carcinomas potentially represents a clinically
useful indicator of breast cancer aggressiveness.